Stay updated on Poziotinib in EGFR Exon 20 Mutant Advanced NSCLC Clinical Trial
Sign up to get notified when there's something new on the Poziotinib in EGFR Exon 20 Mutant Advanced NSCLC Clinical Trial page.

Latest updates to the Poziotinib in EGFR Exon 20 Mutant Advanced NSCLC Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe page's revision tag was updated from v3.6.4 to v3.6.5, indicating a small internal update to the page or CMS. No user-visible content changes are expected.SummaryDifference0.1%

- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe page’s revision label was updated from v3.6.3 to v3.6.4, indicating a minor update to the page’s documentation/display. No study content appears to be changed.SummaryDifference0.1%

- Check51 days agoChange DetectedThe page revision label was updated from v3.6.2 to v3.6.3, signaling a new minor update to the record. This maintenance update does not alter study details or eligibility information.SummaryDifference0.1%

- Check58 days agoChange DetectedThe page revision label was updated from v3.6.0 to v3.6.2, indicating a new build of the study record.SummaryDifference0.1%

- Check73 days agoChange DetectedThe study page now shows recruitment has ended, and new navigation links were added (How to Read a Study Record, Common Questions, How to Join a Study) while the Intervention / Treatment heading was changed to Intervention/Treatment.SummaryDifference0.6%

- Check80 days agoChange DetectedRevision label updated from v3.5.4 to v3.5.5, representing a new site build. No study details or page content were changed.SummaryDifference0.1%

Stay in the know with updates to Poziotinib in EGFR Exon 20 Mutant Advanced NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Poziotinib in EGFR Exon 20 Mutant Advanced NSCLC Clinical Trial page.